Lv4
760 积分 2023-01-29 加入
Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?
23天前
已完结
Cross-regulation between the nervous system and type 2 immunity
1个月前
已完结
The Cytokines of Asthma
2个月前
已完结
Associations between Class I, II, or III Obesity and Health Outcomes
2个月前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
3个月前
已完结
The biology of TREM receptors
3个月前
已完结
Nasopharyngeal carcinoma: an evolving paradigm
4个月前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
6个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
6个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
7个月前
已完结
皖公网安备34019202002308
